Alerts will be sent to your verified email
Verify Email
MEDICAMEQ
|
Medicamen Biotech
|
Kwality Pharma
|
TTK Healthcare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.35 % | 27.8 % | 22.02 % |
|
5yr average Equity Multiplier
|
1.5 | 2.41 | 1.58 |
|
5yr Average Asset Turnover Ratio
|
0.64 | 1.25 | 1.15 |
|
5yr Avg Net Profit Margin
|
10.9 % | 10.06 % | 22.14 % |
|
Price to Book
|
3.45 | 2.45 | 2.15 |
|
P/E
|
55.87 | 43.44 | 32.19 |
|
5yr Avg Cash Conversion Cycle
|
-51.67 Days | 20.73 Days | -41.8 Days |
|
Inventory Days
|
54.49 Days | 46.1 Days | 41.67 Days |
|
Days Receivable
|
166.45 Days | 102.38 Days | 36.67 Days |
|
Days Payable
|
235.49 Days | 91.87 Days | 102.9 Days |
|
5yr Average Interest Coverage Ratio
|
12.44 | 16.27 | 11.04 |
|
5yr Avg ROCE
|
14.6 % | 36.15 % | 9.07 % |
|
5yr Avg Operating Profit Margin
|
18.76 % | 19.6 % | 7.68 % |
|
5 yr average Debt to Equity
|
0.14 | 0.59 | 0.07 |
|
5yr CAGR Net Profit
|
4.13 % | 20.74 % | 92.23 % |
|
5yr Average Return on Assets
|
6.86 % | 12.65 % | 16.15 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
43.21 % | 54.83 % | 74.56 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-1.62 % | 3.31 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | -2.29 % |
|
Medicamen Biotech
|
Kwality Pharma
|
TTK Healthcare
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
